Global Lateral Flow Assays Market Size to Reach $15.7 Billion by 2035

Global lateral flow assays market size reached $8.1 billion in 2025 and is projected to expand to $15.7 billion by 2035, growing at a CAGR of 7.0% during the forecast period (2026–2035). Market growth is supported by rising point-of-care diagnostics adoption, increasing infectious disease testing, and expanding home healthcare demand.

Key Market Drivers

• Growing demand for rapid point-of-care diagnostic testing in clinical and home settings.
• Increasing prevalence of infectious and chronic diseases requiring quick screening tools.
• Rising adoption of self-testing kits for pregnancy, COVID-19, and glucose monitoring.
• Expansion of veterinary diagnostics for livestock and companion animals.
• Technological improvements in assay sensitivity and multiplex detection capabilities.

Browse the full report description of “Lateral Flow Assays Market Size, Share & Trends Analysis By Product (Kits & Reagents, Lateral Flow Readers, and Mobile Readers), By Technique (Sandwich Assays, Competitive Assays, and Multiplex Detection Assay), By Application (Clinical testing, Veterinary Diagnostics), By End-User (Hospitals and Diagnostic Centres, Home Care, Pharmaceuticals and Biotechnology Companies) Forecast Period, (2026-2035)” of https://www.omrglobal.com/industry-reports/lateral-flow-assays-market

Regional Analysis

Asia-Pacific represents a significant growth region due to expanding healthcare infrastructure and large patient populations in china and India. Government initiatives to strengthen disease surveillance and rural healthcare access are supporting adoption of rapid diagnostic technologies across public health programs. Increased domestic manufacturing capacity for diagnostic kits in India and china is also contributing to supply stability and affordability across the region.

North America remains a mature market driven by advanced healthcare systems, high diagnostic spending, and strong regulatory frameworks in the US. Widespread use of rapid antigen tests in hospitals, clinics, and home care settings continues to sustain demand. Public health preparedness initiatives and ongoing monitoring of respiratory infections further support consistent utilization of lateral flow assays across healthcare networks.

Europe demonstrates steady growth supported by public healthcare coverage and regulatory standards that encourage adoption of validated diagnostic tools. Countries across the region continue to integrate rapid testing solutions into primary care and emergency response systems. Increasing focus on decentralized healthcare delivery and aging populations contributes to sustained demand for easy-to-use diagnostic technologies.

Competitive Landscape

Key companies operating in the global lateral flow assays market include Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Siemens Healthineers, and Thermo Fisher Scientific Inc., among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Market Developments

• In July 2025, VolitionRx Ltd. announced successful demonstration of rapid nucleosome quantification in whole venous blood using a simple lateral flow device. The blinded SUMMIT program study analyzed samples from 25 hospital patients in intensive care and emergency department settings, delivering results within minutes.

• In January 2026, Hoffmann?La Roche Ltd. reported its full-year 2025 financial results, highlighting a 7% increase in group sales driven by demand for pharmaceuticals and diagnostics solutions. The announcement reflects continued expansion of the company’s diagnostics portfolio.

 Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By product
  • By technique
  • By application
  • By end user
• Region Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape- Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Siemens Healthineers, and Thermo Fisher Scientific Inc., among others.

 Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Electronics Contract Manufacturing Market Report Segment

By product

• Kits & reagents
• Lateral flow readers
• Mobile readers

By technique

• Sandwich assays
• Competitive assays
• Multiplex detection assays

By application

• Clinical testing
• Veterinary diagnostics

By end user

• Hospitals and diagnostic centres
• Home care
• Pharmaceuticals and biotechnology companies.

 Global Electronics Contract Manufacturing Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/lateral-flow-assays-market